Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Asset Utilization Ratio (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.27 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio fell 31.47% year-over-year to 0.27, compared with a TTM value of 0.27 through Sep 2025, down 31.47%, and an annual FY2024 reading of 0.29, down 29.44% over the prior year.
  • Asset Utilization Ratio was 0.27 for Q3 2025 at China Pharma Holdings, down from 0.31 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.56 in Q1 2021 and bottomed at 0.27 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.43, with a median of 0.44 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio rose 28.07% in 2021, then crashed 31.47% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.47 in 2021, then grew by 0.98% to 0.48 in 2022, then decreased by 7.6% to 0.44 in 2023, then dropped by 27.5% to 0.32 in 2024, then fell by 14.21% to 0.27 in 2025.
  • Business Quant data shows Asset Utilization Ratio for CPHI at 0.27 in Q3 2025, 0.31 in Q2 2025, and 0.3 in Q1 2025.